Procept Biorobotics

Yahoo Finance • last month

PROCEPT BioRobotics (PRCT) Outlook Adjusted as System Replacement Forecasts Shift

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the top robotics to buy according to analysts. On August 7, Wells Fargo maintained its Overweight rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) but reduced its price targe... Full story

Yahoo Finance • last month

Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best medical device stocks to buy according to analysts. On August 8, Leerink Partners analyst Mike Kratky reiterated a Buy rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT)... Full story

Yahoo Finance • 2 months ago

PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline

PROCEPT BioRobotics Corp. (NASDAQ:PRCT [https://www.chartmill.com/stock/quote/PRCT]) reported its second-quarter 2025 financial results, delivering revenue growth but missing market expectations on profitability, leading to a sharp after-h... Full story

Yahoo Finance • 2 months ago

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today r... Full story

Yahoo Finance • 2 months ago

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., Jul... Full story

Yahoo Finance • 2 months ago

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today a... Full story

Yahoo Finance • 2 months ago

Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announce... Full story

Yahoo Finance • 3 months ago

PRCT shares drop 41% after InvestingPro's overvaluation warning proves accurate

When InvestingPro’s Fair Value models flagged (NASDAQ:PRCT) as significantly overvalued in November 2024, the stock was trading at $93.60. Seven months later, this bearish call has proven remarkably accurate, with shares dropping 41% to $5... Full story

Yahoo Finance • 6 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment globally, announced today it will host an i... Full story

Yahoo Finance • 6 months ago

PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires

We recently published a list of the 10 Best Robotics Stocks to Buy According to Billionaires. In this article, we are going to take a look at where PROCEPT BioRobotics Corporation (NASDAQ:PRCT) stands against the other robotics stocks held... Full story

Yahoo Finance • 6 months ago

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

SAN JOSE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announc... Full story

Yahoo Finance • 6 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announc... Full story

Yahoo Finance • 7 months ago

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today re... Full story

Yahoo Finance • 8 months ago

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it w... Full story

Yahoo Finance • 12 months ago

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

PROCEPT BioRobotics SAN JOSE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions... Full story

Yahoo Finance • last year

Is Procept Biorobotics Corp. (PRCT) the Worst AI Stock to Buy?

We recently compiled a list of the 10 Worst AI Stocks to Buy According to Reddit. In this article, we will look at where Procept Biorobotics Corp. (NASDAQ:PRCT) ranks among the worst AI stocks to buy. Are AI Stocks on the Rise Again? In... Full story

Yahoo Finance • last year

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

PROCEPT BioRobotics Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes SAN JOSE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- PROCEPT B... Full story

Yahoo Finance • last year

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

PROCEPT BioRobotics SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, t... Full story

Yahoo Finance • 2 years ago

EVP, CLO, CORP. SEC. Alaleh Nouri Sells 20,000 Shares of PROCEPT BioRobotics Corp

Alaleh Nouri, EVP, CLO, CORP. SEC. of PROCEPT BioRobotics Corp (NASDAQ:PRCT), executed a sale of 20,000 shares in the company on February 9, 2024, according to a recent SEC Filing. The transaction was made at an average price of $49.97 per... Full story

Yahoo Finance • 2 years ago

PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City

SAN JOSE, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced tha... Full story